Who Paid My Doc Search
Menu
Product Program year 2020 Source: CMS Open Payments

Folotyn

Drug Oncology

NDC 72893-003-01

Open in the dashboard

General payments

$103,117

1,277 payments

Research payments

$291,304

12 payments

Through program year 2020, $103,117 in general payments and $291,304 in research payments were reported against Folotyn (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $29,870 763
2020 Research $259,165 6
2019 General $73,246 514
2019 Research $32,138 6

Breakdown

Who paid General payments · program years 2019–2020
  1. Aurobindo Pharma USA, Inc. $103,117 1,277 payments
Top recipients General payments · program year 2020
  1. David Rizzieri Medical Oncology · Charlotte, NC $5,400 18% · 1 payment
  2. Lauren Pinter-Brown Hematology & Oncology · Los Angeles, CA $5,188 17% · 3 payments
  3. Francine Foss Medical Oncology · New Haven, CT $4,000 13% · 3 payments
  4. Baylor University Medical Ctr Teaching hospital · TX $3,500 12% · 2 payments
  5. Baptist Medical Center Teaching hospital · FL $2,500 8% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Medical Oncology Internal Medicine $11,442 49% · 52 practitioners
  2. Hematology & Oncology Internal Medicine $11,167 47% · 191 practitioners
  3. Hematology Internal Medicine $491 2% · 8 practitioners
  4. Radiation Oncology Radiology $152 <1% · 9 practitioners
  5. Dermatology $88 <1% · 1 practitioner

The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. California $7,171 24% · 86 recipients
  2. North Carolina $5,489 18% · 6 recipients
  3. Connecticut $4,000 13% · 1 recipient
  4. Texas $3,641 12% · 5 recipients
  5. Florida $2,961 10% · 32 recipients

The top 5 of 37 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

Records

1,277 general · 12 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record